Cargando…

The Potential Value of EGFR and P53 Immunostaining in Tumors of the Urinary Bladder

The expression of EGFR and p53 has not been adequately studied as a prognostic tool in urinary bladder tumors. We analyzed 74 bladder cancer samples from Egypt for EGFR and p53 expression using immunohistochemistry. The tumors were of different histological types, grades and clinical stages, and wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, N, Elzagheid, A, El-Hashmi, H, Syrjänen, K, Alhakim, S
Formato:	Texto
Lenguaje:	English
Publicado:	CoAction Publishing 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066741/ https://www.ncbi.nlm.nih.gov/pubmed/21483537 http://dx.doi.org/10.4176/090625

Ejemplares similares

Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder
por: El Gehani, Khaled, et al.
Publicado: (2012)

Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostaining
por: Rao, Ram Nawal, et al.
Publicado: (2012)

Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31
por: El Gehani, Khaled, et al.
Publicado: (2011)

The relationship of p53 immunostaining to survival in carcinoma of the lung.
por: McLaren, R., et al.
Publicado: (1992)

p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001)

Negative p53/Positive p21 Immunostaining Is a Predictor of Favorable Response to Chemotherapy in Patients with Locally Advanced Bladder Cancer
por: Koga, Fumitaka, et al.
Publicado: (2000)

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
por: Sung, You-Na, et al.
Publicado: (2022)

Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis
por: Al-Maghrabi, Basim, et al.
Publicado: (2019)

Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies
por: Yildiz, Isil Z, et al.
Publicado: (2009)

Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer
por: Kamoshida, S, et al.
Publicado: (2007)

Diagnostic value of clusterin immunostaining in hepatocellular carcinoma
por: Li, Yuan, et al.
Publicado: (2020)

Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
por: Lipponen, P. K., et al.
Publicado: (1992)

The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer
por: Egger, Eva K., et al.
Publicado: (2023)

Tumourigenesis associated with the p53 tumour suppressor gene.
por: Chang, F., et al.
Publicado: (1993)

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma
por: Kallio, J P, et al.
Publicado: (2003)

CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia
por: Neal, Daniel J., et al.
Publicado: (2020)

Proliferating Trichilemmal Cyst: The Value Of Ki67 Immunostaining
por: Rangel-Gamboa, Lucia, et al.
Publicado: (2013)

Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder
por: hashmi, Atif Ali, et al.
Publicado: (2018)

E-Cadherin Immunostaining in Equine Melanocytic Tumors
por: Pimenta, José, et al.
Publicado: (2023)

Immunostaining for p53 and p16(CDKN2A) Protein Is Not Predictive of Prognosis for Dogs with Malignant Mammary Gland Neoplasms
por: Munday, John S, et al.
Publicado: (2019)

Is membranous location of EGFR or EGFRvIII immunostaining associated with good prognosis in renal cell carcinoma?
por: Modjtahedi, H, et al.
Publicado: (2005)

Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma
por: Tolles, Juliana, et al.
Publicado: (2011)

Reticulin immunostaining revisited
por: Torres, Kara Melissa T., et al.
Publicado: (2016)

p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression.
por: Soini, Y., et al.
Publicado: (1993)

p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer
por: Chen, Liuxi, et al.
Publicado: (2019)

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
por: Nielsen, Kirstine, et al.
Publicado: (2020)

EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma
por: Ding, Jie, et al.
Publicado: (2022)

The Diagnostic Value of p16/Ki67 Dual Immunostaining for Anal Intraepithelial Neoplasia: A Meta-Analysis
por: Chen, Cheng-Chieh, et al.
Publicado: (2020)

Analysis of Spatial Distribution and Prognostic Value of Different Pan Cytokeratin Immunostaining Intensities in Breast Tumor Tissue Sections
por: Vranes, Velicko, et al.
Publicado: (2020)

p53 mutations have no additional prognostic value over stage in bladder cancer.
por: Vet, J. A., et al.
Publicado: (1994)

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value
por: Vannucchi, A M, et al.
Publicado: (2014)

A study of cytokeratin 20 immunostaining in the urothelium of neuropathic bladder of patients with spinal cord injury
por: Vaidyanathan, Subramanian, et al.
Publicado: (2002)

Automated Immunostaining Platform in Cytology
por: Sharma, Shelly, et al.
Publicado: (2021)

Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer
por: Khaled, Hussein M, et al.
Publicado: (2009)

The Expression Patterns of p53 and p16 and an Analysis of a Possible Role of HPV in Primary Adenocarcinoma of the Urinary Bladder
por: Alexander, Riley E., et al.
Publicado: (2014)

Urinary Bladder Hemangioma –A Rare Urinary Bladder Tumor in a Child
por: Jibhkate, Shubhangi, et al.
Publicado: (2015)

The Diagnostic Value of TTF-1, P63, HMWK, CK7, and CD56 Immunostaining in the Classification of Lung Carcinoma
por: Jafarian, Amir Hossein, et al.
Publicado: (2017)

The prognostic value of tumor-associated macrophages detected by immunostaining in diffuse large B cell lymphoma: A meta-analysis
por: Lin, Mei, et al.
Publicado: (2023)

Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case
por: Sada, Haruki, et al.
Publicado: (2015)

Inflammatory pseudotumor of the urinary bladder: A case series among more than 2,000 urinary bladder tumor cases
por: Elawdy, Mohamed M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p4liuli073v862emerka3vponb